Breaking News
Get 55% Off 0
🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?
Explore for Free
Close

Candriam Equities L Oncology Impact C Usd Cap (0P0001F58V)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
255.940 +1.050    +0.41%
20/11 - Closed. Currency in USD
  • Morningstar Rating:
  • Total Assets: 1.7B
Type:  Fund
Market:  Luxembourg
Issuer:  Candriam Luxembourg S.C.A.
ISIN:  LU1864481467 
Asset Class:  Equity
Candriam Equities L Oncology Impact C USD Cap 255.940 +1.050 +0.41%

0P0001F58V Overview

 
On this page you'll find an in-depth profile of Candriam Equities L Oncology Impact C Usd Cap. Learn about the key management, total assets, investment strategy and contact information of 0P0001F58V among other information.
Category

Sector Equity Healthcare

Total Assets

1.7B

Expenses

1.95%

Inception Date

Nov 15, 2018

Investment Strategy

The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) in order to respond to one of the serious long-term challenges of sustainable development. The sub-fund therefore seeks to produce a return for investors while generating a positive social impact over the long term, by selecting companies that address certain societal challenges and mobilise resources in the fight against cancer.

Contact Information

Address Avenue des Arts 58
Brussels,Paris B-1000
Belgium
Phone + 352 2797-1
Fax Brussels

Top Executives

Name Title Since Until
Linden Thomson - 2024 Now
Rudi Van den Eynde Senior Portfolio Manager, Equities 2018 Now
Biography Due to European regulatory GDPR guidelines, Candriam cannot provide personal details as education or professional background to databases outside Europe. Information available on request only.
Servaas Michielssens - 2018 2022
Biography Servaas Michielssens has been a Senior Analyst at Candriam since 2016, and became co-manager of the Biotechnology and Oncology strategy since November 2018. He began his career as a PhD student at the University of Leuven Belgium in 2007, where he obtained his PhD in science in 2011. In 2012 he became a postdoctoral scholar at the Max Planck Institute for Biophysical Chemistry in Germany. Servaas holds a master degree in chemistry from the University of Leuven, Belgium and a PhD in science from the same university. Servaas is also a CFA charterholder.
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0001F58V Comments

Write your thoughts about Candriam Equities L Oncology Impact C Usd Cap
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email